Leading Manufacturer for 4-Methylthiazole-5-Carboxaldehyde - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex
Leading Manufacturer for 4-Methylthiazole-5-Carboxaldehyde - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex Detail:
Product Detail
|
NO. |
Products |
CAS No. |
Application |
Key Quality Indicator |
||||
|
Purity |
Isomer |
SI * |
Max * |
Moisture |
||||
|
1 |
Fmoc-Lys(Mtt)-OH | 167393-62-6 | Lysine side chain modification |
≥99.0% |
≤0.1% |
≤0.2% |
≤0.3% |
≤1.0% |
|
2 |
Fmoc-Lys(Alloc)-OH | 146982-27-6 | Lysine side chain modification |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
3 |
Fmoc-Lys(ivDde)-OH | 150629-67-7 | Lysine side chain modification |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
4 |
Fmoc-Lys(Mmt)-OH | 159857-60-0 | Lysine side chain modification |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
5 |
Fmoc-Glu-OtBu | 84793-07-7 | LiraglutideSemaglutide |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
6 |
Glu-OtBu | 45120-30-7 | LiraglutideSemaglutide |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
7 |
Octadecanedioic acid | 871-70-5 | Semaglutide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
8 |
Octadecanedioic acid mono-tert-butyl ester | 843666-40-0 | Semaglutide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
9 |
tBu-OOC-C16-CO-Glu-OtBu | 1188328-39-3 | SemaglutideFragment A |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
10 |
AEEA | 134978-97-5 | SemaglutideAlbuvirtide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
11 |
AEEA-OH.HCl | 134979-01-4 | SemaglutideAlbuvirtide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
12 |
Fmoc-AEEA-OH | 166108-71-0 | SemaglutideAlbuvirtide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
13 |
Boc-AEEA-OH | 108466-89-3 | Semaglutide |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
14 |
AEEA-AEEA | 1143516-05-5 | Semaglutide |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
15 |
Fmoc-AEEA-AEEA-OH | 560088-89-3 | SemaglutideFragment B |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
16 |
Octa(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA-OH | 1118767-16-0 | SemaglutideFragment C |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
17 |
tBu-OOC-C16-CO-Glu(AEEA-AEEA-NHS)-OtBu | 1118767-15-9 | SemaglutideFragment D |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
|
18 |
Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH | 1662688-20-1 | Semaglutide Fragment E |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
|
19 |
Boc-His(Trt)-OH | 32926-43-5 | The end is histidine |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤4.0% |
|
20 |
Fmoc-Aib-OH | 94744-50-0 | Semaglutide |
≥99.5% |
/ |
≤0.1% |
≤0.2% |
≤1.0% |
|
21 |
Boc-His(Trt)-Aib-OH | 2061897-68-3 | Semaglutide |
≥99.0% |
≤0.1% |
≤0.2% |
≤0.3% |
≤2.0% |
|
22 |
Fmoc-Glu(OtBu)-Gly-OH | 866044-63-5 | GLP-1 analogue |
≥99.5% |
≤0.1% |
≤0.2% |
≤0.2% |
≤1.0% |
|
23 |
Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH | 1169630-31-2？ | Semaglutide Fragment F |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
24 |
Boc-His(Trt)-Aib-Glu(OtBu)-Gly-NHS | 1169630-40-3 | Semaglutide Fragment G |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
|
25 |
Fmoc-Arg(pbf)-Gly-OH | 660846-80-0 | GLP-1 analogue |
≥99.5% |
≤0.1% |
≤0.2% |
≤0.2% |
≤1.0% |
|
26 |
Fmoc-Ala-Ala-OH | 87512-31-0 | GLP-1 analogue |
≥99.5% |
≤0.1% |
≤0.2% |
≤0.2% |
≤1.0% |
|
27 |
Fmoc-Thr(tBu)-Phe-OH | 1260609-75-3 ? | GLP-1 analogue |
≥99.5% |
≤0.1% |
≤0.2% |
≤0.2% |
≤1.0% |
|
28 |
Palmitic acid | 1957/10/3 | Liraglutide Fragment 1 |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
29 |
Palm-Glu-OtBu | NA | Liraglutide Fragment 2 |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
30 |
Palm-Glu(NES)-OtBu | NA | Liraglutide Fragment 3 |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
|
31 |
Fmoc-Lys(Palm-Glu-OtBu)-OH | 1491158-62-3 | Liraglutide |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
32 |
Hexadecanedioic acid | 505-54-4 | Insulin degludec |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
33 |
Hexadecanedioic acid mono-tert-butyl ester | 843666-27-3 | Insulin degludec |
≥99.0% |
/ |
≤0.2% |
≤0.3% |
≤1.0% |
|
34 |
tBu-OOC-C14-CO-Glu-OtBu | NA | Insulin degludec Fragment I |
≥98.0% |
≤0.2% |
≤0.5% |
≤0.5% |
≤1.0% |
|
35 |
tBu-OOC-C14-CO-Glu(NES)-OtBu | NA | Insulin degludec Fragment II |
≥96.0% |
≤0.5% |
≤1.0% |
≤1.0% |
≤1.0% |
SI *= Specific Impurity
Max*= Max Unknown Impurity
Other Indicator:
- Acetic Acid: ≤0.02% (All Products)
- Ethyl Acetate: ≤0.5% (All Products)
- Alcohol: ≤0.5% (All Products)
Sanitization
Sanitization of distribution system, including loop and storage tank is performed by Pasteurization. When Pasteurization sanitization is performed, the purified water in tank is heated up to 80°C and start to circulate by distribution system. The sanitization lasts 1 hour after reaching 80°C. Sanitization is performed every quarter. The purified water system sanitization logbook was checked with no excursion highlighted.
Product detail pictures:
Related Product Guide:
We have been committed to offering easy,time-saving and money-saving one-stop purchasing service of consumer for Leading Manufacturer for 4-Methylthiazole-5-Carboxaldehyde - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex , The product will supply to all over the world, such as: Gambia, Nicaragua, Uganda, We offer OEM services and replacement parts to meet the varying needs of our customers. We offer competitive price for quality products and we will make certain your shipment is handled quickly by our logistics department. We sincerely hope to have the opportunity to meet with you and see how we can help you further your own business.
By Judy from Turkey - 2017.12.02 14:11
The customer service reprersentative explained very detailed, service attitude is very good, reply is very timely and comprehensive, a happy communication! We hope to have a opportunity to cooperate.
By Michaelia from Grenada - 2017.01.28 18:53
